Literature DB >> 10880877

Involvement of Ca(2+) in antiarrhythmic effect of ischemic preconditioning in isolated rat heart.

K Hong1, K F Kusano, H Morita, Y Fujimoto, K Nakamura, H Yamanari, T Ohe.   

Abstract

We investigated the relationship between the effects of ischemic preconditioning (IPC) and Ca(2+) preconditioning (CPC) on reperfusion-induced arrhythmias. In the control group (noPC), Langendorff-perfused rat hearts were subjected to 5-min zero-flow global ischemia (I) followed by 15-min reperfusion (I/R). In ischemic preconditioning groups (IPC), the hearts were subjected to three cycles of 3-min global ischemia and 5-min reperfusion. In the CPC group, the hearts were exposed to three cycles of 3-min perfusion of higher Ca(2+) (2.3 mmol/l Ca(2+)) followed by 5-min perfusion of normal 1.3 mmol/l Ca(2+), and the hearts were then subjected to I/R. Verapamil was administered in several hearts of the IPC group (VR+IPC). Ventricular arrhythmias upon reperfusion were less frequently seen in the IPC and CPC groups than in the noPC and VR+IPC groups. IPC and CPC could attenuate conduction delay and enhance shortening of the monophasic action potential duration during ischemia. The ventricular fibrillation threshold measured at 1-min reperfusion was significantly higher in the IPC and CPC groups than in the noPC and VR+IPC groups. Verapamil completely abolished the salutary effects of IPC. These results demonstrate that Ca(2+) plays an important role in the antiarrhythmic effect of IPC during reperfusion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10880877     DOI: 10.2170/jjphysiol.50.207

Source DB:  PubMed          Journal:  Jpn J Physiol        ISSN: 0021-521X


  1 in total

1.  Cardiac sodium/calcium exchanger preconditioning promotes anti-arrhythmic and cardioprotective effects through mitochondrial calcium-activated potassium channel.

Authors:  Jian-Ying Zhang; Kang Cheng; Dong Lai; Ling-Heng Kong; Min Shen; Fu Yi; Bing Liu; Feng Wu; Jing-Jun Zhou
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.